Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin effect on cell surface molecules
NCT03753867Phase 1Withdrawn
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2019
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of acitretin in human immunodeficiency virus infection (HIV), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Number of participants with treatment-related adverse events at 5 months. Planned start Jan 2019; status: withdrawn.
02
Drugs
acitretin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03753867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03753867.